Literature DB >> 19043398

Strategies for endovascular mitral valve repair.

M J Davidson1, L H Cohn.   

Abstract

Technological advances have recently enabled mitral valve repair to be performed using endovascular techniques and thus open the possibility of nonsurgical treatment of mitral valve disease. While balloon valvotomy has been applied to mitral stenosis for over 20 years, a number of devices aimed at correcting mitral regurgitation are currently in preclinical and clinical development. While some of these, such as edge-to-edge repair, are catheter adaptations of established surgical techniques, others represent true departures from the current surgical paradigms of correcting mitral regurgitation. This review will summarize the current status of percutaneous transcatheter techniques for mitral valve repair. Included are balloon mitral valvotomy, indirect annuloplasty, direct annuloplasty, ventricular shape change, and edge-to-edge repair. These techniques certainly represent a new interdisciplinary paradigm between cardiac surgery and interventional cardiology and may be the next frontier in minimally-invasive cardiac surgery.

Entities:  

Mesh:

Year:  2008        PMID: 19043398

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Conformational constraints on side chains in protein residues increase their information content.

Authors:  A J Bojarski; M Nowak; B Testa
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

2.  Hybrid theatres: nicety or necessity?

Authors:  Mark L Field; John Sammut; Manoj Kuduvalli; Aung Oo; Abbas Rashid
Journal:  J R Soc Med       Date:  2009-03       Impact factor: 5.344

Review 3.  [Percutaneous approaches for mitral valve interventions--a real alternative technique for standard cardiac surgery?].

Authors:  Christian Frerker; Ulrich Schäfer; Dimitry Schewel; Matthias Krüger; Rainer Malisius; Carsten Schneider; Stephan Geidel; Martin Bergmann; Karl-Heinz Kuck
Journal:  Herz       Date:  2009-09       Impact factor: 1.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.